Lungs

AB1442 PREDICTIVE FACTORS FOR DOSE REDUCTION AND DISCONTINUATION OF NINTEDANIB IN FIBROTIC INTERSTITIAL LUNG DISEASES: A REAL-LIFE, SINGLE-CENTER STUDY
C. Ferreira, E. Costa, P. Pereira, A. M. Correia, A. R. Pedroso, R. Matos, M. Cunha Rodrigues, E. Padrão, J. Silva, J. Neves, R. Rolo

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 2077-2078; DOI: 10.1136/annrheumdis-2024-eular.5399
AB1447 IMMUNE RELATED ADVERSE EVENTS DUE TO CHECKPOINT INHIBITOR THERAPY IN CANCER PATIENTS WITH RHEUMATOID ARTHRITIS: A MEDICARE CLAIMS STUDY
D. Jannat-Khah, F. Xie, A. Saxena, J. R. Curtis, A. Bass

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 2081-2082; DOI: 10.1136/annrheumdis-2024-eular.4406
AB1474 NINTEDANIB IN AUTOIMMUNE DISEASE-RELATED INTERSTITIAL LUNG DISEASE: REAL-LIFE EFFECTIVENESS, SAFETY AND TOLERANCE IN A SPANISH MULTICENTER STUDY
P. Pérez-García, M. Retuerto-Guerrero, Y. Chuquimia, L. Sierra Herránz, J. Loarce-Martos, B. Atienza-Mateo, C. Merino Argumánez, M. Pavía Pascual, B. Miguel Ibáñez, J. Ordas Martínez, P. Baenas González, C. Sieiro Santos, C. Moriano, I. González, C. Díez, I. González Fernández, C. Álvarez Castro, E. Gutierrez, E. Diez Álvarez

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 2101-2102; DOI: 10.1136/annrheumdis-2024-eular.4530
AB1483 NINTEDANIB IN PROGRESSIVE PULMONARY FIBROSIS. COMPARING SUBGROUPS IN CLINICAL PRACTICE. EXPERIENCE OF PULMONOLOGISTS AND RHEUMATOLOGISTS
P. Pérez-García, M. Retuerto-Guerrero, Y. Chuquimia, L. Sierra Herránz, J. Loarce-Martos, B. Atienza-Mateo, C. Merino Argumánez, M. Pavía Pascual, B. Miguel Ibáñez, J. Ordas Martínez, P. Baenas González, C. Sieiro Santos, C. Moriano, I. González, C. Díez, I. González Fernández, C. Álvarez Castro, E. Gutierrez, E. Diez Álvarez

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 2108-2109; DOI: 10.1136/annrheumdis-2024-eular.5829
AB1489 HIGH RESOLUTION COMPUTED TOMOGRAPHY (HRCT) COMPARING INTERSTITIAL LUNG DISEASE (ILD) FEATURES ACROSS CONNECTIVE TISSUE DISEASES (CTDS) TO CONSIDER IMPACT ON MORBIDITY/MORTALITY - A SCOPING REVIEW
D. Furst, T. Woodworth, O. Morgan, N. Fathy

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 2112-2113; DOI: 10.1136/annrheumdis-2024-eular.2243
AB1491 QUANTIFICATION OF LUNG INVOLVEMENT IN INFLAMMATORY RHEUMATIC DISEASE-INTERSTITIAL LUNG DISEASE (IRD-ILD): A COMPARATIVE STUDY BETWEEN SYMPTOMATIC AND ASYMPTOMATIC PATIENTS USING AI-BASED HRCT ANALYSIS
T. Hoffmann, U. Teichgräber, B. Lassen-Schmidt, D. Renz, L. B. Brüheim, M. Krämer, P. Oelzner, J. Böttcher, F. Güttler, G. Wolf, A. Pfeil

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 2113-2114; DOI: 10.1136/annrheumdis-2024-eular.2680
AB1490 JAK INHIBITORS AND INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC AUTOIMMUNE DISEASES (SADS-ILD): A SYSTEMATIC REVIEW OF THE LITERATURE
R. Rego Salgueiro, C. Sieiro Santos

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 2113; DOI: 10.1136/annrheumdis-2024-eular.2358
AB1498 PULMONARY FUNCTION TRAJECTORY IN ALL SUBTYPES OF ILD AND ASSOCIATED RISK FACTORS FOR DECLINE
S. Eisa, M. Rabbani, S. Sankar, A. Ibrahim, A. Podlasek, K. “Suthar, S. Ansari, G. M. Koduri

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 2118-2119; DOI: 10.1136/annrheumdis-2024-eular.5190
AB1533 ANTI-RO52 POSITIVITY IS ASSOCIATED WITH POORER LUNG FUNCTION AT DIAGNOSIS IN CONNECTIVE TISSUE DISEASE AND IDIOPATHIC INFLAMMATORY MYOPATHY ASSOCIATED INTERSTITIAL LUNG DISEASE
R. Harrington, R. Conway, R. Fahy

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 2137-2138; DOI: 10.1136/annrheumdis-2024-eular.5150
AB1535 A PROFILE OF SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASE-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION (SARD-PAH) FROM WESTERN INDIA: A SINGLE CENTRE RETROSPECTIVE STUDY
S. Jagennath, A. Kumar P H, R. Choudhary, M. K. Garg, M. Gopalakrishnan

Annals of the Rheumatic Diseases Jun 2024, 83 (Suppl 1) 2138-2139; DOI: 10.1136/annrheumdis-2024-eular.5328

Main menu

Lungs

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Lungs

Pages